Home › Stocks › LXEO › All Fund Holders
LXEO — LEXEO THERAPEUTICS INC · All Fund Holders
Funds holding (latest): 35 · Reported value held: $183.51M
| Fund | Quarter | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|---|
| Vanguard Group history | Q4 2025 | 3.89M | $38.67M | 0.00% | Add |
| Janus Henderson Group history | Q1 2026 | 4.98M | $28.51M | 0.01% | Reduce |
| BlackRock Inc history | Q2 2026 | 5.74M | $26.72M | 0.00% | Add |
| Citadel Advisors history | Q2 2026 | 3.90M | $18.15M | 0.02% | Add |
| Millennium Management history | Q2 2026 | 2.83M | $13.19M | 0.01% | Add |
| Balyasny Asset Management history | Q2 2026 | 2.41M | $11.23M | 0.01% | Add |
| Goldman Sachs Group history | Q2 2026 | 2.15M | $10.01M | 0.00% | Add |
| Point72 Asset Management history | Q1 2026 | 1.68M | $9.65M | 0.01% | Reduce |
| Geode Capital Management history | Q2 2026 | 1.75M | $8.14M | 0.00% | Add |
| Northern Trust Corp history | Q2 2026 | 867.39K | $4.04M | 0.00% | Add |
| Bank of America Corp history | Q2 2026 | 490.33K | $2.28M | 0.00% | Hold |
| Morgan Stanley history | Q2 2026 | 395.10K | $1.84M | 0.00% | Reduce |
| UBS Group AG history | Q2 2026 | 354.04K | $1.65M | 0.00% | Add |
| AQR Capital Management history | Q2 2026 | 256.66K | $1.19M | 0.00% | Reduce |
| Renaissance Technologies history | Q2 2026 | 250.37K | $1.17M | 0.00% | New |
| Two Sigma Investments history | Q1 2026 | 181.68K | $1.04M | 0.00% | Reduce |
| Wellington Management Group history | Q2 2026 | 202.38K | $942.09K | 0.00% | Add |
| BNY Mellon history | Q2 2026 | 183.88K | $855.98K | 0.00% | Add |
| Charles Schwab Investment Management history | Q2 2026 | 172.61K | $803.50K | 0.00% | Reduce |
| Fidelity Management & Research (FMR) history | Q2 2026 | 141.15K | $657.03K | 0.00% | Add |
| JPMorgan Chase & Co history | Q2 2026 | 96.29K | $463.15K | 0.00% | New |
| Citigroup Inc history | Q2 2026 | 93.74K | $436.37K | 0.00% | Add |
| Deutsche Bank AG history | Q2 2026 | 82.29K | $383.49K | 0.00% | Add |
| Invesco Ltd history | Q2 2026 | 76.22K | $354.80K | 0.00% | Add |
| Marshall Wace history | Q1 2025 | 81.01K | $281.10K | 0.00% | Add |
| Wells Fargo & Co history | Q2 2026 | 59.37K | $276.34K | 0.00% | Add |
| Franklin Resources history | Q2 2024 | 14.04K | $225.12K | 0.00% | New |
| D. E. Shaw & Co history | Q2 2026 | 19.87K | $92.48K | 0.00% | Reduce |
| Manulife Financial history | Q2 2026 | 19.80K | $92.19K | 0.00% | Add |
| CPP Investments history | Q2 2026 | 18.50K | $86.12K | 0.00% | New |
| Prudential Financial history | Q2 2026 | 11.59K | $53.93K | 0.00% | New |
| Legal & General Investment Management America history | Q2 2026 | 6.88K | $32.04K | 0.00% | Add |
| PNC Financial Services history | Q2 2026 | 234 | $1.09K | 0.00% | Reduce |
| T. Rowe Price Associates history | Q2 2026 | 58.19K | $271 | 0.00% | Add |
| Lazard Asset Management history | Q4 2024 | 33 | $0 | — | Hold |